LTPM CHINA Shines at ACHEMA 2024, Showcasing Advanced Pharmaceutical Machinery

LTPM CHINA at ACHEMA 2024: A Step Forward in Pharmaceutical Manufacturing

2024 ACHEMA 3

From June 10 to 14, 2024, LTPM CHINA proudly showcased its cutting-edge pharmaceutical machinery at ACHEMA 2024 in Frankfurt, Germany. As one of the most prestigious global exhibitions for chemical, pharmaceutical, and process industries, ACHEMA brought together professionals, manufacturers, and researchers from around the world.

2024 ACHEMA 4

During the event, LTPM CHINA displayed its vial liquid washing-drying-filling-stoppering production line and liquid dosage production line, among other state-of-the-art equipment. Our booth attracted a steady stream of visitors, including pharmaceutical manufacturers, engineers, and industry experts eager to explore high-efficiency solutions for pharmaceutical production.

Through in-depth discussions and live demonstrations, our team engaged with industry leaders, potential clients, and strategic partners. The exhibition provided valuable insights into the latest trends and customer needs, reinforcing LTPM CHINA’s commitment to innovation, quality, and customized pharmaceutical solutions.

The positive feedback and interest in our machines reaffirm our dedication to providing advanced, reliable, and cost-effective pharmaceutical production solutions for global markets. The success at ACHEMA 2024 strengthens our position in the European market and opens new opportunities for future collaborations.

We thank all visitors, partners, and organizers for making this event a success. We look forward to continuing our mission of delivering top-tier pharmaceutical machinery worldwide.


Share:
×

Contact Us

*We respect your privacy. When you submit your contact information, we agree to only contact you in accordance with our Privacy Policy.

×

Inquire

*Name
*Email
Company Name
Tel
*Message

*We respect your privacy. When you submit your contact information, we agree to only contact you in accordance with our Privacy Policy.